PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR

@article{Bernardi2006PMLIH,
  title={PML inhibits HIF-1$\alpha$ translation and neoangiogenesis through repression of mTOR},
  author={Rosa Bernardi and Ilhem Guernah and David K. Jin and Silvia Grisendi and Andrea Alimonti and Julie Teruya-Feldstein and Carlos Cordon-Cardo and M. Celeste Simon and Shahin Rafii and Pier Paolo Pandolfi},
  journal={Nature},
  year={2006},
  volume={442},
  pages={779-785}
}
Loss of the promyelocytic leukaemia (PML) tumour suppressor has been observed in several human cancers. The tumour-suppressive function of PML has been attributed to its ability to induce growth arrest, cellular senescence and apoptosis. Here we identify PML as a critical inhibitor of neoangiogenesis (the formation of new blood vessels) in vivo, in both ischaemic and neoplastic conditions, through the control of protein translation. We demonstrate that in hypoxic conditions PML acts as a… Expand

Figures from this paper

Pml represses tumour progression through inhibition of mTOR
TLDR
It is found that combined inactivation of Pml and Tsc2 results in aberrant TORC1 activity both in pre‐tumoural kidneys as well as in kidney lesions, demonstrating that activation of mTOR is critical for tumours progression, but not for tumour initiation in the kidney. Expand
Angiogenesis: Familiar faces and new connections
TLDR
PML exerts some of its tumour-suppressive role by controlling the ‘angiogenic switch’ — an essential process in tumorigenesis that is often induced in response to intra-tumoural hypoxia, and has important prognostic and therapeutic implications for the treatment of ischaemic conditions and cancer. Expand
Mutual Regulation of Hypoxia-Inducible Factor and Mammalian Target of Rapamycin as a Function of Oxygen Availability
TLDR
It is shown that hypoxic repression of rpS6 is largely dependent on HIF, implicating a negative feedback loop, which may influence cellular translational rates and metabolic homeostasis, which would add to the difficulties of other established therapeutic strategies in hypoxic cancer tissues. Expand
The role of PML ubiquitination in human malignancies
TLDR
The current understanding of the PML ubiquitination/degradation pathways in human cancers is summarized and the potential of targeting PML Ubiquitination pathways for anti-cancer therapeutic strategies is discussed. Expand
PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway
TLDR
It is demonstrated that the inducible or transfected expression of the acute promyelocytic leukemia (APL)-specific PML-RAR α fusion protein upregulates constitutive autophagy activation in leukemic and nonleukemic cells, as evaluated by hallmarks for autophile activity including transmission electron microscopy. Expand
SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.
TLDR
A novel pathway of PML degradation in ccRCC that involves SCP downregulation is defined, revealing contributions of this pathway toccRCC progression and offering a mechanistic rationale for combination therapies that jointly target PML degraded and mTOR inhibition for ccR CC treatment. Expand
Modulation of M2‐type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein
TLDR
It is shown that cytoplasmic PML (cPML) directly interacts with M2‐type pyruvate kinase (PKM2), a key regulator of carbon fate, which suggests that cPML plays a role in tumor metabolism through its interaction with PKM2. Expand
Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence
TLDR
It is demonstrated that upregulation of PML translation plays a central role in oncogenic K‐RAS‐induced OIS and that selective translation initiation plays a critical role in tumour suppression with important therapeutic implications for the treatment of solid tumours and APL. Expand
Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression.
TLDR
It is shown that complete Pml inactivation, in a context of p53 heterozygosity, redistributes and expands the tumor spectrum leading to the formation of angiosarcomas and increased lymphomagenesis. Expand
CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor
TLDR
The findings that PML undergoes ubiquitin/proteasome-mediated degradation in immortalized and tumor derived cell lines are reviewed and suggest that CK2 inhibitors may be beneficial anti-cancer drugs. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
The PML growth-suppressor has an altered expression in human oncogenesis.
TLDR
Overexpression of the nuclear body-associated PML protein induces a sharp reduction in growth rates in vitro and in vivo, and observations point to the existence of a consistent deregulation in the expression of the PML growth-suppressor during human oncogenesis. Expand
Pml is essential for multiple apoptotic pathways
TLDR
It is demonstrated that Pml is a mediator of multiple apoptotic signals, and implicate inhibition of apoptosis in the pathogenesis of APL. Expand
Identification of a tumour suppressor network opposing nuclear Akt function
TLDR
It is demonstrated that Pml orchestrates a nuclear tumour suppressor network for inactivation of nuclear pAkt, and thus highlights the importance of AKT compartmentalization in human cancer pathogenesis and treatment. Expand
When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy.
TLDR
Inhibition of the proteasome in conjunction with topoisomerase inhibition has shown some promise in the treatment of experimental cancer and may impact on the hypoxic adaptation of tumour cells. Expand
Cytoplasmic PML function in TGF-beta signalling.
TLDR
It is shown that cytoplasmic Pml is an essential modulator of TGF-beta signalling, and further implicate deregulated T GF- beta signalling in cancer pathogenesis. Expand
PML regulates p53 stability by sequestering Mdm2 to the nucleolus
TLDR
PML enhances p53 stability by sequestering Mdm2 to the nucleolus and physically associates with the nucleolar protein L11, and that L11 knockdown impairs the ability of PML to localize to nucleoli after DNA damage, demonstrating an unexpected role ofPML in theucleolar network for tumour suppression. Expand
mTOR-targeted therapy of cancer with rapamycin derivatives.
TLDR
Evidence suggests that rapamycin derivatives could induce G1-S cell cycle delay and eventually apoptosis depending on inner cellular characteristics of tumour cells, and strategies aimed at detecting human tumours that express BCL-2 and other anti-apoptotic proteins might allow identification of rap Amycin-resistant tumours. Expand
PML nuclear bodies and apoptosis
TLDR
A variety of stress-related signalling pathways dramatically modulate the formation of PML NBs, which may provide a clue as to their physiological function. Expand
Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression
TLDR
It is demonstrated that PML acts in vivo as a tumor suppressor by rendering the cells resistant to proapoptotic and differentiating stimuli, and PML haploinsufficiency and the functional impairment of PML by PMLRARα are critical events in APL pathogenesis. Expand
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.
TLDR
It is shown that mTOR inhibition by hypoxia requires the TSC1/TSC2 tumor suppressor complex and the Hypoxia-inducible gene REDD1/RTP801 to be inhibited, and that down-regulation of mTOR activity by hyp oxia requires de novo mRNA synthesis and correlates with increased expression of the hypoxIA-Inducible REDD 1 gene. Expand
...
1
2
3
4
5
...